Expert Insight: The future of method development is in Analytical Quality by Design, but which tools do we need to get there?

---

Dr. Mark Eggink, Principle Scientist, Byondis

Analytical Quality by Design (AQbD) will start to play a more predominant role in the analytical field. Implementing AQbD in your workflows can have several advantages, for example it can make post-approval changes of an analytical method less complicated and time consuming. An AQbD flow is built-up of different parts, the most important being the Analytical Target Profile (ATP), which defines the requirements of the Critical Quality Attribute (CQA); from there an analytical technique can be selected. Furthermore, the use of a Design of Experiment (DoE) approach is increasing in popularity in analytical method development, as it enables fast and efficient development of robust methods.

In this SelectScience^® webinar, Dr. Mark Eggink, Principle Scientist, Byondis, presents the analysis of an ATP, the AQbD flow, and the benefits of using DoE software in combination with separation software during method development of a size exclusion chromatography method for a mAb/ADC.

Key learning objectives:

• Analytical Quality by Design
• Analytical Target Profile
• Implementation of AQbD in biopharmaceutical development
• Design of Experiments software for monoclonal and ADC assays

Who Should Attend?

• Principal investigators
• Consultants
• R&D directors
• Academia
• Presenters

The live webinar takes place on Wednesday, July 15, 2020 at:

• 16:00 BST
• 17:00 CEST
• 08:00 PDT
• 11:00 EDT

Register to watch the full webinar here>>

SelectScience runs 3-4 webinars a month across various scientific topics, discover more of our upcoming webinars>>